🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
562,02 USD
Máx. histórico
608,49
2 días
Split 2:1 del 23/09/2009
Caída desde máximo
-7,64%
Rango 52 semanas
444,04 – 614,23
Variación hoy
-0,65%
Cierre anterior
565,72
Rango de hoy
559,41 – 569,45
Volumen hoy
454.934
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,96%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,22 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 1 hora
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 04/01/2008 | 50,64 | 52,35 | 50,64 | 51,25 | -0,44% | 3,39% | 1.606.400 |
| 03/01/2008 | 49,52 | 51,50 | 49,52 | 51,48 | +3,90% | 3,99% | 1.757.000 |
| 02/01/2008 | 48,85 | 50,57 | 48,54 | 49,55 | +1,47% | 4,17% | 1.411.400 |
| 31/12/2007 | 49,15 | 49,38 | 48,53 | 48,83 | -0,89% | 1,74% | 630.000 |
| 28/12/2007 | 50,00 | 50,20 | 49,07 | 49,27 | -0,67% | 2,26% | 431.200 |
| 27/12/2007 | 50,42 | 50,42 | 48,77 | 49,60 | -1,43% | 3,27% | 876.200 |
| 26/12/2007 | 50,00 | 51,23 | 49,60 | 50,32 | +0,25% | 3,27% | 837.600 |
| 24/12/2007 | 49,89 | 51,44 | 49,89 | 50,19 | +0,53% | 3,11% | 583.800 |
| 21/12/2007 | 51,14 | 51,20 | 49,93 | 49,93 | -0,76% | 2,49% | 1.154.000 |
| 20/12/2007 | 49,22 | 50,41 | 49,05 | 50,31 | +1,48% | 2,76% | 784.000 |
| 19/12/2007 | 49,44 | 50,12 | 49,21 | 49,57 | +0,27% | 1,84% | 1.136.800 |
| 18/12/2007 | 49,62 | 50,30 | 48,88 | 49,44 | -0,18% | 2,86% | 1.442.400 |
| 17/12/2007 | 51,11 | 51,14 | 49,52 | 49,53 | -3,61% | 3,18% | 1.242.800 |
| 14/12/2007 | 52,00 | 54,42 | 51,00 | 51,38 | -2,67% | 6,59% | 1.631.600 |
| 13/12/2007 | 51,78 | 52,87 | 50,95 | 52,79 | +1,29% | 3,72% | 1.272.600 |
| 12/12/2007 | 54,00 | 54,16 | 51,00 | 52,12 | -0,87% | 5,85% | 1.270.800 |
| 11/12/2007 | 54,24 | 54,50 | 52,29 | 52,58 | -3,19% | 4,07% | 1.387.800 |
| 10/12/2007 | 50,87 | 55,35 | 50,87 | 54,31 | +6,29% | 8,81% | 4.606.800 |
| 07/12/2007 | 49,25 | 51,68 | 49,25 | 51,10 | +4,19% | 4,93% | 2.474.800 |
| 06/12/2007 | 49,25 | 49,73 | 47,81 | 49,04 | -0,67% | 3,91% | 2.115.200 |
| 05/12/2007 | 49,53 | 50,69 | 49,20 | 49,37 | -1,55% | 3,02% | 2.137.600 |
| 04/12/2007 | 50,89 | 51,76 | 50,02 | 50,15 | -0,24% | 3,42% | 1.250.800 |
| 03/12/2007 | 50,38 | 51,12 | 49,76 | 50,27 | +0,45% | 2,71% | 1.624.000 |
| 30/11/2007 | 51,72 | 52,15 | 49,91 | 50,04 | -2,59% | 4,33% | 1.262.800 |
| 29/11/2007 | 51,25 | 52,01 | 50,65 | 51,37 | +0,43% | 2,65% | 835.000 |
| 28/11/2007 | 50,08 | 51,58 | 49,50 | 51,15 | +2,81% | 4,15% | 1.610.800 |
| 27/11/2007 | 49,00 | 50,50 | 49,00 | 49,75 | +1,64% | 3,07% | 1.161.600 |
| 26/11/2007 | 49,45 | 50,42 | 48,84 | 48,95 | -1,19% | 3,21% | 986.200 |
| 23/11/2007 | 49,02 | 49,85 | 48,63 | 49,54 | +1,44% | 2,49% | 228.600 |
| 21/11/2007 | 48,92 | 49,74 | 48,41 | 48,83 | -0,81% | 2,72% | 735.600 |